{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:43:54Z","timestamp":1770500634910,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf00920636","type":"journal-article","created":{"date-parts":[[2005,1,2]],"date-time":"2005-01-02T07:52:01Z","timestamp":1104652321000},"page":"58-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":203,"title":["Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases"],"prefix":"10.1007","volume":"13","author":[{"given":"Mansour","family":"Al-Janadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suliman","family":"Al-Balla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Al-Dalaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Raziuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00920636_CR1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJM198710083171506","volume":"317","author":"CA Dinarello","year":"1987","unstructured":"Dinarello CA, Mier JW: Current concepts, lymphokines. N Engl J Med 317:940\u2013945, 1987","journal-title":"N Engl J Med"},{"key":"BF00920636_CR2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.iy.07.040189.003205","volume":"7","author":"B Beutler","year":"1989","unstructured":"Beutler B, Cerami A: The biology of cachectin\/TNF\u2014a primary mediator of the host response. Annu Rev Immunol 7:625\u2013655, 1989","journal-title":"Annu Rev Immunol"},{"key":"BF00920636_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V74.1.1.1","volume":"74","author":"T Kishimoto","year":"1989","unstructured":"Kishimoto T: The biology of interleukin-6. Blood 74:1\u201310, 1989","journal-title":"Blood"},{"key":"BF00920636_CR4","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.144.10.3762","volume":"144","author":"MC Sneller","year":"1990","unstructured":"Sneller MC, Strober W: Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol 144:3762\u20133769, 1990","journal-title":"J Immunol"},{"key":"BF00920636_CR5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0002-9343(91)80082-W","volume":"90","author":"A Schattner","year":"1991","unstructured":"Schattner A, Lachini M, Livnen A, Pras M, Hahn T: Tumor necrosis factor in familial mediterranean fever. Am J Med 90:434\u2013438, 1991","journal-title":"Am J Med"},{"key":"BF00920636_CR6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.147.1.117","volume":"147","author":"M Linker-Israeli","year":"1991","unstructured":"Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinberg JR: Elevated levels of endogenous IL-6 in systemic lupus erythematosus: A putative role in pathogenesis. J Immunol 147:117\u2013123, 1991","journal-title":"J Immunol"},{"key":"BF00920636_CR7","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.142.3.948","volume":"142","author":"DC Helfgott","year":"1989","unstructured":"Helfgott DC, Tatter SB, Santhanam U, Clarick RM, Bhardwaj N, May T, Sehgal PB: Multiple forms of IFN-B2\/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 142:948\u2013953, 1989","journal-title":"J Immunol"},{"key":"BF00920636_CR8","first-page":"192","volume":"129","author":"IA Clark","year":"1987","unstructured":"Clark IA, Cowden WB, Butcher GA, Hunt NH: Possible role of tumor necrosis factor in the pathology of malaria. Am J Pathol 129:192\u2013199, 1987","journal-title":"Am J Pathol"},{"key":"BF00920636_CR9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/infdis\/163.4.853","volume":"163","author":"M Barral-Netto","year":"1991","unstructured":"Barral-Netto M, Badaro R, Almeida R, Santos S, Badaro F, Falcoff R: Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J Infect Dis 163:853\u2013857, 1991","journal-title":"J Infect Dis"},{"key":"BF00920636_CR10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/096120339200100209","volume":"1","author":"J Akocer-Varela","year":"1992","unstructured":"Akocer-Varela J, Aleman-Hoey D, Alarcon-Segovia D: Interleukin-1 and interleukin-6 are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T cell activation markers. Lupus 1:111\u2013117, 1992","journal-title":"Lupus"},{"key":"BF00920636_CR11","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.4049\/jimmunol.143.7.2153","volume":"143","author":"N Bhardwaj","year":"1989","unstructured":"Bhardwaj N, Santhanam U, Lau L, Tatter S, Ghrayed J, Rivelis M, Steinman R, Sehgal P, May L: IL-6\/IFN-B2 in synovial effusion of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources. J Immunol 143:2153\u20132159, 1989","journal-title":"J Immunol"},{"key":"BF00920636_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM196803072781004","volume":"9","author":"PH Schur","year":"1968","unstructured":"Schur PH, Sandson J: Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 9:533\u2013538, 1968","journal-title":"N Engl J Med"},{"key":"BF00920636_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.iy.01.040183.001135","volume":"1","author":"HR Smith","year":"1983","unstructured":"Smith HR, Steinberg AD: Autoimmunity\u2014a perspective. Ann Rev Immunol 1:175\u2013189, 1983","journal-title":"Ann Rev Immunol"},{"key":"BF00920636_CR14","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.131.4.1797","volume":"131","author":"GC Tsokos","year":"1983","unstructured":"Tsokos GC, Margrath IT, Balow JE: Epstein-Barr virus induces normal B cell responses but defective suppressor T cell response in patients with systemic lupus erythematosus. J Immunol 131:1797\u20131801, 1983","journal-title":"J Immunol"},{"key":"BF00920636_CR15","first-page":"1315","volume":"16","author":"S Raziuddin","year":"1989","unstructured":"Raziuddin S, Nur MA, Al-Wabel AA: Selective loss of the CD4+ inducers of suppressor T cell subsets (2H4+) in active systemic lupus erythematosus. J Rheumatol 16:1315\u20131319, 1989","journal-title":"J Rheumatol"},{"key":"BF00920636_CR16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0090-1229(88)90155-9","volume":"48","author":"S Raziuddin","year":"1988","unstructured":"Raziuddin S, Danial HB, Kelley M: OKT4 T cell abnormality in patients with systemic lupus erythematosus: HLA-DR antigen expressions. Clin Immunol Immunopathol 48:42\u201349, 1988","journal-title":"Clin Immunol Immunopathol"},{"key":"BF00920636_CR17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.4049\/jimmunol.121.4.1473","volume":"121","author":"AS Fauci","year":"1978","unstructured":"Fauci AS, Steinberg AD, Haynes BF, Whalen G: Immunoregulatory aberration in systemic lupus erythematosus. J Immunol 121:1473\u20131479, 1978","journal-title":"J Immunol"},{"key":"BF00920636_CR18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/art.1780311103","volume":"31","author":"DH Campen","year":"1988","unstructured":"Campen DH, Horwitz DA, Quismorio FP, Ehresmann GR, Martin WJ: Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arth Rheum 31:1358\u20131364, 1988","journal-title":"Arth Rheum"},{"key":"BF00920636_CR19","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/art.1780271201","volume":"27","author":"JG Wilson","year":"1984","unstructured":"Wilson JG, Fearon DT: Altered expression of complement receptors as a pathogenetic factor in systemic lupus erythematosus. Arth Rheum 27:1321\u20131327, 1984","journal-title":"Arth Rheum"},{"key":"BF00920636_CR20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1172\/JCI111261","volume":"73","author":"C Morimoto","year":"1984","unstructured":"Morimoto C, Reinherz EL, Distaso JA, Steinberg AD, Schlossman SF: Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies and T cell functions. J Clin Invest 73:689\u2013700, 1984","journal-title":"J Clin Invest"},{"key":"BF00920636_CR21","first-page":"831","volume":"18","author":"S Raziuddin","year":"1991","unstructured":"Raziuddin S, Al-Janadi MA, Al-Wabel AA: Soluble interleukin-2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus. J Rheumatol 18:831\u2013836, 1991","journal-title":"J Rheumatol"},{"key":"BF00920636_CR22","first-page":"271","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arth Rheum 25:271\u20131277, 1982","journal-title":"Arth Rheum"},{"key":"BF00920636_CR23","first-page":"317","volume":"30","author":"FC Arnett","year":"1987","unstructured":"Arnett FC, Edworthy S, Block DA,et al.: The 1987 revised ARA criteria for rheumatoid arthritis. Arth Rheum 30:317, 1987","journal-title":"Arth Rheum"},{"key":"BF00920636_CR24","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-50118-0","volume-title":"Sjogren's Syndrome","author":"N Talal","year":"1987","unstructured":"Talal N, Moutsopoulos HM, Kasan S: Sjogren's Syndrome. Heidelberg, Springer-Verlag, 1987"},{"key":"BF00920636_CR25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","volume":"38","author":"HA Bird","year":"1979","unstructured":"Bird HA, Esselinck W, Dixon AS, Mowat AG, Wood PHN: An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434\u2013439, 1979","journal-title":"Ann Rheum Dis"},{"key":"BF00920636_CR26","doi-asserted-by":"crossref","unstructured":"Raziuddin S, Al-Janadi MA, Al-Wabel AA: T cell receptor alpha\/beta chain-CD3 protein complex defect in systemic lupus erythematosus. T cell function. Am J Med 1992 (in press)","DOI":"10.1016\/0002-9343(92)90178-E"},{"key":"BF00920636_CR27","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(86)92007-6","volume":"2","author":"P Scuderi","year":"1986","unstructured":"Scuderi P, Sterling K, Lam K, Finley P, Ryan K, Ray C, Peterson E, Slymen D, Salmon S: Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 2:1364\u20131365, 1986","journal-title":"Lancet"},{"key":"BF00920636_CR28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0002-9343(86)90413-4","volume":"81","author":"GC Tsokos","year":"1986","unstructured":"Tsokos GC, Smith PL, Balow JE: Development of hypogammaglobulinemia in a patient with systemic lupus erythematosus. Am J Med 81:1081\u20131084, 1986","journal-title":"Am J Med"},{"key":"BF00920636_CR29","first-page":"466","volume":"72","author":"S Raziuddin","year":"1988","unstructured":"Raziuddin S, Danial HB: OKT4+ T cell deficiency and an association of immunoglobulin deficiency in systemic lupus erythematosus. Clin Exp Immunol 72:466\u2013469, 1988","journal-title":"Clin Exp Immunol"},{"key":"BF00920636_CR30","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/art.1780331218","volume":"33","author":"S Raziuddin","year":"1990","unstructured":"Raziuddin S, Nur MA, Al-Janadi MA: CD4+ T lymphocyte deficiency and function in systemic lupus erythematosus and rheumatoid arthritis. Arth Rheum 33:1864\u20131865, 1990","journal-title":"Arth Rheum"},{"key":"BF00920636_CR31","first-page":"55","volume":"15","author":"RJ Warrington","year":"1988","unstructured":"Warrington RJ: B cell differentiation factor production in systemic lupus erythematosus. J Rheumatol 15:55\u201358, 1988","journal-title":"J Rheumatol"},{"key":"BF00920636_CR32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0090-1229(76)90110-0","volume":"6","author":"NI Abdou","year":"1976","unstructured":"Abdou NI, Sagawa A, Rascual E, Habert J, Sadeghee S: Suppressor T cell abnormality in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol 6:192\u2013199, 1976","journal-title":"Clin Immunol Immunopathol"},{"key":"BF00920636_CR33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780310605","volume":"31","author":"RE Wolf","year":"1988","unstructured":"Wolf RE, Brelsford WG: Soluble interleukin-2 receptors in systemic lupus erythematosus. Arth Rheum 31:729\u2013735, 1988","journal-title":"Arth Rheum"},{"key":"BF00920636_CR34","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.130.6.2651","volume":"130","author":"M Linker-Israeli","year":"1983","unstructured":"Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA: Defective production of interleukin-1 and interleukin-2 in patients with systemic lupus erythematosus. J Immunol 130:2651\u20132655, 1983","journal-title":"J Immunol"},{"key":"BF00920636_CR35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/art.1780310614","volume":"31","author":"FA Houssiau","year":"1988","unstructured":"Houssiau FA, Devogelaer J-P, Van Damme J, Deuxchaisnes C, Van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arth Rheum 31:784\u2013788, 1988","journal-title":"Arth Rheum"},{"key":"BF00920636_CR36","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.4049\/jimmunol.144.9.3347","volume":"144","author":"GS Firestein","year":"1990","unstructured":"Firestein GS, Alvaro-Garcia JM, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 144:3347\u20133353, 1990","journal-title":"J Immunol"},{"key":"BF00920636_CR37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/rheumatology\/29.6.456","volume":"29","author":"B Dasgupta","year":"1990","unstructured":"Dasgupta B, Panayi GS: Interleukin-6 in serum of patients with polymalgia rheumatica and giant cell arteritis. Br J Rheumatol 29:456\u2013458, 1990","journal-title":"Br J Rheumatol"},{"key":"BF00920636_CR38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-1229(92)90084-2","volume":"63","author":"M Linker-Israeli","year":"1992","unstructured":"Linker-Israeli M: Cytokine abnormalities in human lupus. Clin Immunol Immunopathol 63:10\u201312, 1992","journal-title":"Clin Immunol Immunopathol"},{"key":"BF00920636_CR39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/096120339200100209","volume":"1","author":"J Alcocer-Varela","year":"1992","unstructured":"Alcocer-Varela J, Aleman-Hoey D, Alarcon-Segovia D: Interleukin-1, interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlates with local late T-cell activation markers. Lupus 1:111\u2013117, 1992","journal-title":"Lupus"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00920636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00920636\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00920636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00920636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T10:07:21Z","timestamp":1682935641000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00920636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF00920636"],"URL":"https:\/\/doi.org\/10.1007\/bf00920636","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]},"assertion":[{"value":"15 September 1992","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}